Clinical trial
A Study to Compare the Efficacy of Levocetirizine to Placebo in Reducing…
NCT00291642 · UCB Pharma, Industry · Completed
Key facts
| NCT number | NCT00291642 |
|---|---|
| Title | A Study to Compare the Efficacy of Levocetirizine to Placebo in Reducing Symptoms of Seasonal Allergic Rhinitis (SAR) in Sensitive Subjects Exposed to Ragweed Pollen |
| Official title | Double Blind, Double-dummy, Five Parallel Groups, Randomized, Exploratory Clinical Trial to Compare the Efficacy of Single Dose of Levocetirizine 2.5 mg Oral Drops (5 mg/mL), Levocetirizine 5 mg Oral Tablets, Cetirizine 5 mg Oral Drops (10 mg/mL) and Cetirizine 10 mg Oral Tablets to Placebo in… |
| Lead sponsor | UCB Pharma, Industry |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Rhinitis, Allergic, Seasonal |
| Intervention type | Drug |
| Interventions | Placebo drops, Placebo tablets matching to levocetirizine, Placebo tablets matching to cetirizine, Levocetirizine drops, Levocetirizine tablets, Cetirizine drops, Cetirizine tablets |
| Enrollment | 551 |
| Start date | Jan 1, 2006 |
| Primary completion | Apr 1, 2006 |
| Completion | Apr 1, 2006 |
| First posted | Feb 14, 2006 |
| Last update posted | Sep 11, 2018 |
| Countries | Canada |
At a glance
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: